Solar and Biotech Stocks Are Leading Today's Gainers
U.S. stocks opened higher today, with the Dow Jones up by triple digits at one point in time, before turning south and briefly dipping into red.
Ayala Pharmaceuticals Inc. (ADXS)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fifth Lane Capital Cavan Copeland | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 658,858 | $0.00 | 1,094,091 | 2023-10-18 | Filing | |
| $0.00 | 658,858 | $0.00 | 2,584,909 | 2023-10-18 | Filing | |
| $3.80 | 3,000 | $11,391.00 | 13,476 | 2019-04-10 | Filing | |
| $1.20 | 33,333 | $39,999.60 | 157,143 | 2018-09-11 | Filing | |
| $14.47 | 12,100 | $175,087.00 | 5,939,366 | 2015-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.55 | 2,401 | $1,320.55 | 10,476 | 2020-03-13 | Filing | |
| $0.58 | 200 | $116.00 | 12,877 | 2020-03-12 | Filing | |
| $0.67 | 399 | $267.33 | 13,077 | 2020-03-11 | Filing | |
| $0.58 | 3,963 | $2,298.54 | 231,206 | 2018-11-05 | Filing | |
| $0.56 | 8,491 | $4,754.96 | 235,169 | 2018-11-02 | Filing |
Institutional Investors' Holdings
News See All
Hedge Funds Think Only 1 Of These 3 Trending Stocks Is Worth Buying
Shares of Advaxis, Inc. (NASDAQ:ADXS), Nu Skin Enterprises, Inc. (NYSE:NUS), and Dex Media Inc (NASDAQ:DXM) are making big moves in the wrong direction, for various reasons.
Broadfin Capital Increases Its Profitable Stake In Advaxis Inc. (ADXS) To 5.27%
As disclosed in a Schedule 13G filing with the U.S. Securities and Exchange Commission, Kevin Kotler’s Broadfin Capital holds an ownership stake of 1.66 million shares in Advaxis Inc.
Advaxis, Inc. (ADXS) Down 10% Today: What Do Hedge Funds Think about this Stock?
Advaxis, Inc. (NASDAQ:ADXS) is a biotechnology company which focuses on developing drug technology for treating Cancer. Alongside many other biotech stocks, Advaxis, Inc.
Alere Inc (ALR), Lion Biotech (LBIO), Genocea Biosciences Inc (GNCA), Advaxis Inc (ADXS) Among Broadfin's Top New Health Picks
Broadfin Capital, LLC is a New York-based hedge fund, whose $1.28-billion equity portfolio is invested in healthcare companies.
Hedge Fund Resource Center